NEW YORK, July 02, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.
LendingClub Corporation LC
Lead Plaintiff Deadline: July 2, 2018
Class Period: February 28, 2015 and April 25, 2018
Get additional information: http://www.wongesq.com/pslra-c/lendingclub-corporation-2?wire=3.
Esperion Therapeutics, Inc. ESPR
Lead Plaintiff Deadline: July 6, 2018
Class Period: February 22, 2017 to May 1, 2018
Get additional information: http://www.wongesq.com/pslra-c/esperion-therapeutics-inc-2?wire=3.
InnerWorkings, Inc. INWK
Lead Plaintiff Deadline: July 9, 2018
Class Period: August 11, 2015 and May 7, 2018
Get additional information: http://www.wongesq.com/pslra-c/innerworkings-inc-2?wire=3.
Flex Ltd. FLEX
Lead Plaintiff Deadline: July 9, 2018
Class Period: January 26, 2017 and April 26, 2018
Get additional information: http://www.wongesq.com/pslra-c/flex-ltd-2?wire=3.
Kulicke and Soffa Industries, Inc. KLIC
Lead Plaintiff Deadline: July 10, 2018
Class Period: November 16, 2017 and May 10, 2018
Get additional information: http://www.wongesq.com/pslra-c/kulicke-and-soffa-industries-inc-2?wire=3.
Symantec Corp. SYMC
Lead Plaintiff Deadline: July 16, 2018
Class Period: May 20, 2017 and May 10, 2018
Get additional information: http://www.wongesq.com/pslra-c/symantec?wire=3.
Micro Focus International plc MFGP
Lead Plaintiff Deadline: July 23, 2018
Class Period: September 1, 2017 and March 19, 2018; pursuant to the August 4 and August 22, 2017 Prospectuses
Get additional information: http://www.wongesq.com/pslra-c/micro-focus-international-plc?wire=3.
Fluor Corporation FLR
Lead Plaintiff Deadline: July 24, 2018
Class Period: August 14, 2013 and May 3, 2018
Get additional information: http://www.wongesq.com/pslra-c/fluor-corporation?wire=3.
Recro Pharma, Inc. REPH
Lead Plaintiff Deadline: July 30, 2018
Class Period: July 31, 2017 and May 23, 2018
Get additional information: http://www.wongesq.com/pslra-c/recro-pharma-inc-2?wire=3.
Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.